A Phase 1 Placebo-Controlled Trial to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Food Effect of Single Escalating Oral Doses of PF-04991532 in Healthy Adult Subjects.
Phase of Trial: Phase I
Latest Information Update: 04 Aug 2010
At a glance
- Drugs PF 4991532 (Primary)
- Indications Diabetes mellitus; Glucose metabolism disorders; Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Pfizer
- 04 Aug 2010 Actual end date added to 1 Jun 2010 as reported by ClinicalTrials.gov.
- 04 Aug 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 21 May 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.